Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-640-0 | CAS number: 7665-72-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In the key study for acute oral toxicity study conducted with the target substance tert-butyl glycidyl ether the oral LD50 was determined to be 2000 mg/kg bw. Based on this result classification as Acute Tox 4, H302 is warranted. That classification for Acute Oral Toxicity is warranted is further supported by an acute oral toxicity study conducted with the structural analogue n-butyl glycidyl ether. The oral LD50 obtained from an acute oral toxicity study in mice treated with this read-across partner was 1530 mg/kg bw.
In an acute inhalation toxicity study five female Sprague Dawley rats were whole-body exposed for 7 hours to a vapour concentration of 17.72 mg/L of the target substance. No adverse signs of toxicity were observed. Based on the results the LD0 can be considered to be 17.72 mg/L and in accordance with the CLP regulation 1272/2008 no classification for acute inhalation toxicity is warranted.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1972-01-12 to 1972-07-03
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- not specified
- Test type:
- other:
- Limit test:
- no
- Specific details on test material used for the study:
- - Name: 1-tert-Butoxy-2,3-epoxypropane
- Purity: 99 %
- Appearance: Colourless liquid
- Solubility at room temperature: <1% for water, >25 % for acetone and benzene - Species:
- rat
- Strain:
- not specified
- Sex:
- male
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Doses:
- 126, 252, 500, 1000 and 2000 mg/kg bw
- No. of animals per sex per dose:
- 2 males
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: All animals were weighed and observed at intervals over a two week post feeding or until any weight loss was regained and the animals appeared healthy.
- Necropsy of survivors performed: Yes, the following tissues were examined: trachea, lung, heart, liver, kidneys, adrenal, spllen, pancreas, stomach, small intestine, large intestine and reproductive organs. - Statistics:
- Not specified
- Preliminary study:
- n.a.
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- One out of two rats died at 2000 mg/kg bw. No further mortality observed.
- Clinical signs:
- not specified
- Body weight:
- No decrease in body weight was observed.
- Gross pathology:
- From all animals, one animal per dose group were gross pathological assessed. No gross pathological findings were seen in the animals from the three low dose groups (126, 252 and 500 mg/kg bw). In animal 11 from the dose group 1000 mg/kg bw the following findings were reported: (external) There was a very slight accumulation of darkened material near the external naries. In all probability this was increased porphyrin sections. (internal) The mucosal surface of the stomach was slightly edematous. There was no large pocket of edematous fluid as was decribed for the high dose rat. In all probability the diffuse edema was related to treatment. In animmal 02 from the high dose group the following findings were reported: (external) There was a slight accumulation of dark staining material external to the naries. In all probability this was increased porphyrin sections. (internal) The mucousal surface of the stomach contained some edematous type of fluid. This principally was a large accumulation located between the mucosal and underlying musculature. This area was also congested. In all probability this was related to treatment. It could not be determined that this lesion was associated with possibly some trauma associated with the intubation process. No other visble lesions were noted.
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- In an acute oral toxicity study conducted equivalent to OECD TG 401, the target substance (99% purity) was orally administered to 2 male rats per dose group comprising of concentrations 126, 252, 500, 1000 and 2000 mg/kg bw. The animals were observed for 14 days. Observations were made at frequent intervals to check the body weights. The body weights and the pathological observations had no treatment related effects and no mortality was observed up to 1000 mg/kg bw. One out of two rats treated with 2000 mg/kg bw died. Hence, according to this study, it can be concluded that the LD50 of the substance is 2000 mg/kg bw.
- Executive summary:
In an acute oral toxicity study conducted equivalent to OECD TG 401, the target substance (99% purity) was orally administered to 2 male rats per dose group comprising of concentrations 126, 252, 500, 1000 and 2000 mg/kg bw. The animals were observed for 14 days. Observations were made at frequent intervals to check the body weights. The body weights and the pathological observations had no treatment related effects and no mortality was observed up to 1000 mg/kg bw. One out of two rats treated with 2000 mg/kg bw died. Hence, according to this study, it can be concluded that the LD50 of the substance is 2000 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Comparable to guideline study
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1973-02-22
- Reliability:
- 2 (reliable with restrictions)
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- - Principle of test:
To evaluate the the acute inhalation toxicity for t-Butylglycidyl ether monomer
- Short description of test conditions: Five female Sprague Dawley albino rats were placed in a 19 liter round glass exposure chamber made from a battery jar. Air was metered through the test material maintained at room temperature or at 140 °C into the chamber at the rate of approximately 1 liter per minute, for seven hours. The nominal concentration was calculated from the ratio of the weight of material vaporized to the total volume of air bubbled through the material during the entire exposure period. The rats were weighed and examined prior to use. During, and for two weeks following exposure, the rats were examined frequently for changes in demeanor and untoward physical effects , including changes in body weight. A gross pathological examination of one of the test animals was performed 24 hours post-exposure. The remaining test animals and untreated controls were sacrificed two weeks post-exposure and subjected to a pathological examination.
- Parameters analysed / observed: Body weight, gross pathology - GLP compliance:
- not specified
- Test type:
- traditional method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- ENVIRONMENTAL CONDITIONS
- Temperature (°C): Room temperature - Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Round glass exposure chamber
- Exposure chamber volume: 19 L
- Method of holding animals in test chamber: Animmals were placed in the jar
- Source and rate of air: Air was metered through the test material at the rate of 1 L/ min
- Temperature: room temperature or 140 °C
TEST ATMOSPHERE
- Brief description of analytical method used: The nominal concentration was calculated from the ratio of the weight of material vaporized to the total volume of air bubbled through the material during the entire exposure period - Duration of exposure:
- 7 h
- Concentrations:
- - 17.72 mg/L (3333 ppm), generated at room temperature
- 8 6.02 mg /L (16180 ppm), generated at 140 °C - No. of animals per sex per dose:
- 5 females
- Control animals:
- no
- Details on study design:
- Five female Sprague Dawley albino rats were placed in 19 liter round glass exposure chamber made from a battery jar. Air was metered through the test material maintained at room temperature or at 140 °C into the chamber at the rats of approximately 1 liter per minute, for seven hours. The nominal concentration was calculated from the ratio of the weight of material vaporized to the total volume of air bubbled through the material during he entire exposure period. The rats were weighed and examined prior to use. During and for two weeks following exposure, the rats were examined frequently fro changes in demeanor and untoward physical effects, including changes in body weight. A gross pathological examinantion of one of the test animals was performed 24 hours post exposure. The remaining test animals and untreated controls were sacrificed two weeks post-exposure and subjected to a pathological examination.
- Statistics:
- Mean body weight and standard deviation
- Key result
- Sex:
- female
- Dose descriptor:
- LC0
- Effect level:
- 17.72 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 7 h
- Key result
- Sex:
- female
- Dose descriptor:
- LC50
- Effect level:
- < 86.02 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 7 h
- Mortality:
- No treatment related mortality was observed at a concentration of 17.72 mg/L. At a test concentration of 86.02 mg/L, four out of five rats died after 5.5 to 6.5 hours of exposure.
- Clinical signs:
- other: No treatment related signs were observed at concentration of 17.72 mg/L. At a test concentration of 86.02 mg/L, all animals exhibited eye irritation and subsequent corneal opacity as well as gasping and irregular breathing during exposure.
- Body weight:
- No significant change in body weight was observed.
- Gross pathology:
- No treatment related signs were observed at concentration of 17.72 mg/L. At a test concentration of 86.02 mg/L, gross pathology of the animals revealed pulmonary edema and effusion.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In an acute inhalation toxicity study, five female Sprague Dawley rats were exposed to 17.72 mg/L and 86.02 mg/L vapour concentrations of the test material for 7 hours. At the test concentration 17.72 mg/L, no treatment related effects were observed. However, at a test concentration of 86.02 mg/L, four out of five rats died. Hence, it can be concluded that the test material was well tolerated up to 17.72 mg/L (LC0) without showing any mortality and classification for acute inhalation toxicity is not warranted.
- Executive summary:
In an acute inhalation toxicity study, five female Sprague Dawley rats were exposed whole-body to vapour concentrations of 17.72 mg/L and 86.02 mg/L of t-Butylglycidyl ether monomer for 7 hours. At a test item concentration of 17.72 mg/L, no treatment related effects were observed. However, at a test item concentration of 86.02 mg/L, four out of five rats died. Hence, it can be concluded that the test material was well tolerated up to 17.72 mg/L (LC0) without showing any mortality and classification for acute inhalation toxicity is not warranted.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- Comparable guideline study
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In the key study for acute oral toxicity study conducted with the target substance tert-butyl glycidyl ether the oral LD50 was determined to be 2000 mg/kg bw. Based on this result classification as Acute Tox 4, H302 is warranted. That classification for Acute Oral Toxicity is warranted is further supported by an acute oral toxicity study conducted with the structural analogue n-butyl glycidyl ether. The oral LD50 obtained from an acute oral toxicity study in mice treated with this read-across partner was 1530 mg/kg bw.
In an acute inhalation toxicity study five female Sprague Dawley rats were whole-body exposed for 7 hours to a vapour concentration of 17.72 mg/L of the target substance. No adverse signs of toxicity were observed. Based on the results the LD0 can be considered to be 17.72 mg/L and in accordance with the CLP regulation 1272/2008 no classification for acute inhalation toxicity is warranted.
Justification for classification or non-classification
Based on the available results, classification for acute oral toxicity is warranted (Acute Tox 4, H302). Based on the results from an acute inhalation toxicity study no classification is warranted for acute inhalation toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.